Accumetrics, Inc. Report issue

For profit Phase 4
Founded: San Diego CA United States (1996)
Status: Acquired by ITC (2013)

Organization Overview

First Clinical Trial
2008
NCT00645918
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (3)

acetylsalicylic acid (aspirin) (2 trials)

clopidogrel (plavix) (2 trials)

prasugrel (effient) (1 trial)

Drugs in Other Trials (2)

desmopressin (ddavp) (1 trial)

platelets (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Atherosclerosis (Phase 4)

Cardiovascular Diseases (Phase 4)

Cerebral Infarction (Phase 4)

Infarction (Phase 4)

Ischemia (Phase 4)

Stroke (Phase 4)

Thrombosis (Phase 4)

Vascular Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5